Skip to main content

Table 3 Pricing of anti-malarial drugs in Burundi, by sector

From: Anti-malarial market and policy surveys in sub-Saharan Africa

Survey area Number of outlets Median price, US$ (range)
Government/Public Sector   
   AS+AQ 31 0.16 (0.00–0.16)
   Halofantrine 2 8.90 (8.35–9.44)
   Quinine injection 20 0.24 (0.00–0.48)
Charity   
   AS+AQ 15 0.16 (0.08–2.42)
   Quinine injection 9 0.32 (0.16–0.81)
   Quinine tablets 1 1.66 (0.51–2.58)
Private   
   AQ 1 0.32 (0.32–0.32)
   AM+LUM 2 0.60 (0.40–0.81)
   AS+AQ 7 0.40 (0.17–2.82)
   DHA+PQ 1 2.82 (2.82–2.82)
   Dihydroartemisinin 1 4.84 (4.84–4.84)
   Dihydroartemisinin* 3 4.03 (4.03–4.84)
   Halofantrine 3 9.68 (8.47–9.68)
   Halofantrine* 11 9.68 (7.66–11.29)
   Quinine injection 17 0.40 (0.24–1.61)
   Quinine tablets 29 1.61 (0.32–3.39)
  1. For tablets the price is for a course; for injections is for a single injection. The price per course is neither for adults nor for adolescents or children. Often when an adult treatment is not available; multiple adolescent or child doses are given to supplement and vice-versa.
  2. *These were found in stand-alone pharmacies that were not attached to, or part of, any health facility.